Kevin Healy | AIChE

Kevin Healy

University of California, Berkeley

Kevin E. Healy, Ph.D. is the Jan Fandrianto and Selfia Halim Distinguished Professor in Engineering at the University of California at Berkeley in the Departments of Bioengineering, and Materials Science and Engineering. He served as Chair of the Department of Bioengineering from 2011 to 2015. He received a B.Sc. in Chemical Engineering from the University of Rochester in 1983. He obtained graduate degrees in Bioengineering from the University of Pennsylvania (M.Eng.: 1985; Ph.D.: 1990). He is a thought leader and innovator working at the interface between stem cells and materials science to develop dynamic engineered systems to explore both fundamental biological phenomena and new applications in translational medicine. His group currently conducts research in the areas of: bioinspired stem cell microenvironments to control stem cell lineage specification and self-organization into microtissues or organs; bioinspired systems for regenerative medicine; biological interfaces; and, microphysiological systems for drug toxicity screening. Major discoveries from his laboratory have centered on the control of cell fate and tissue formation in contract with materials that are tunable in both their biological content and mechanical properties. These materials find applications in medicine, dentistry, and biotechnology. Prof. Healy has authored or co-authored more than 350 published articles, abstracts, and book chapters. He recently co-edited a multi-volume scholarly reference work on the biomaterials field, containing an all-encompassing comprehensive treatise that accurately captures the diversity, breadth, and dimensions of the field. He is an elected Fellow of the American Institute of Medical and Biological Engineering (AIMBE), American Association for the Advancement of Science (AAAS), Biomaterials Science and Engineering (FBSE), Biomedical Engineering Society (BMES), and recently received an Alexander von Humboldt Foundation Award. He has chaired the Gordon Research Conference on Biomaterials and Biocompatibility, and has been honored with the 2011 Clemson award for outstanding contributions to basic biomaterials science. He is a named inventor on numerous issued United States and international patents relating to biomaterials, therapeutics, stem cells, and medical devices, and has founded several companies to develop these systems for applications in biotechnology and regenerative medicine. He is currently an Associate Editor of The Journal of Biomedical Materials Research and Regenerative Engineering and Translational Medicine. He has served on numerous panels and grant review study sections for N.I.H. and international scientific agencies. He has given more than 300 invited lectures in the fields of Biomedical Engineering and Biomaterials.